Corvus Pharmaceuticals Statistics
Total Valuation
CRVS has a market cap or net worth of $438.14 million. The enterprise value is $364.82 million.
Important Dates
The next estimated earnings date is Tuesday, November 11, 2025, after market close.
Earnings Date | Nov 11, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
CRVS has 74.51 million shares outstanding. The number of shares has increased by 37.88% in one year.
Current Share Class | 74.51M |
Shares Outstanding | 74.51M |
Shares Change (YoY) | +37.88% |
Shares Change (QoQ) | +3.49% |
Owned by Insiders (%) | 3.96% |
Owned by Institutions (%) | 37.25% |
Float | 57.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 5.46 |
P/TBV Ratio | 5.46 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.91, with a Debt / Equity ratio of 0.01.
Current Ratio | 8.91 |
Quick Ratio | 8.78 |
Debt / Equity | 0.01 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -68.67% and return on invested capital (ROIC) is -33.34%.
Return on Equity (ROE) | -68.67% |
Return on Assets (ROA) | -28.84% |
Return on Invested Capital (ROIC) | -33.34% |
Return on Capital Employed (ROCE) | -43.90% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.46M |
Employee Count | 31 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +15.29% in the last 52 weeks. The beta is 0.51, so CRVS's price volatility has been lower than the market average.
Beta (5Y) | 0.51 |
52-Week Price Change | +15.29% |
50-Day Moving Average | 4.90 |
200-Day Moving Average | 4.71 |
Relative Strength Index (RSI) | 59.43 |
Average Volume (20 Days) | 592,405 |
Short Selling Information
The latest short interest is 9.59 million, so 12.88% of the outstanding shares have been sold short.
Short Interest | 9.59M |
Short Previous Month | 9.29M |
Short % of Shares Out | 12.88% |
Short % of Float | 16.73% |
Short Ratio (days to cover) | 19.13 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -35.54M |
Pretax Income | n/a |
Net Income | -45.14M |
EBITDA | -35.45M |
EBIT | -35.54M |
Earnings Per Share (EPS) | -$1.02 |
Full Income Statement Balance Sheet
The company has $74.41 million in cash and $1.08 million in debt, giving a net cash position of $73.32 million or $0.98 per share.
Cash & Cash Equivalents | 74.41M |
Total Debt | 1.08M |
Net Cash | 73.32M |
Net Cash Per Share | $0.98 |
Equity (Book Value) | 80.23M |
Book Value Per Share | 1.08 |
Working Capital | 67.28M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$28.83 million and capital expenditures -$149,000, giving a free cash flow of -$28.98 million.
Operating Cash Flow | -28.83M |
Capital Expenditures | -149,000 |
Free Cash Flow | -28.98M |
FCF Per Share | -$0.39 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
CRVS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -37.88% |
Shareholder Yield | -37.88% |
Earnings Yield | -10.30% |
FCF Yield | -6.61% |
Analyst Forecast
The average price target for CRVS is $15.00, which is 155.10% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $15.00 |
Price Target Difference | 155.10% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 2 |